» Articles » PMID: 20300528

A at Single Nucleotide Polymorphism-358 is Required for G at -420 to Confer the Highest Plasma Resistin in the General Japanese Population

Abstract

Insulin resistance is a feature of type 2 diabetes. Resistin, secreted from adipocytes, causes insulin resistance in mice. We previously reported that the G/G genotype of single nucleotide polymorphism (SNP) at -420 (rs1862513) in the human resistin gene (RETN) increased susceptibility to type 2 diabetes by enhancing its promoter activity. Plasma resistin was highest in Japanese subjects with G/G genotype, followed by C/G, and C/C. In this study, we cross-sectionally analyzed plasma resistin and SNPs in the RETN region in 2,019 community-dwelling Japanese subjects. Plasma resistin was associated with SNP-638 (rs34861192), SNP-537 (rs34124816), SNP-420, SNP-358 (rs3219175), SNP+299 (rs3745367), and SNP+1263 (rs3745369) (P<10(-13) in all cases). SNP-638, SNP -420, SNP-358, and SNP+157 were in the same linkage disequilibrium (LD) block. SNP-358 and SNP-638 were nearly in complete LD (r(2) = 0.98), and were tightly correlated with SNP-420 (r(2) = 0.50, and 0.51, respectively). The correlation between either SNP-358 (or SNP-638) or SNP-420 and plasma resistin appeared to be strong (risk alleles for high plasma resistin; A at SNP-358, r(2) = 0.5224, P = 4.94x10(-324); G at SNP-420, r(2) = 0.2616, P = 1.71x10(-133)). In haplotypes determined by SNP-420 and SNP-358, the estimated frequencies for C-G, G-A, and G-G were 0.6700, 0.2005, and 0.1284, respectively, and C-A was rare (0.0011), suggesting that subjects with A at -358, generally had G at -420. This G-A haplotype conferred the highest plasma resistin (8.24 ng/ml difference/allele compared to C-G, P<0.0001). In THP-1 cells, the RETN promoter with the G-A haplotype showed the highest activity. Nuclear proteins specifically recognized one base difference at SNP-358, but not at SNP-638. Therefore, A at -358 is required for G at -420 to confer the highest plasma resistin in the general Japanese population. In Caucasians, the association between SNP-420 and plasma resistin is not strong, and A at -358 may not exist, suggesting that SNP-358 could explain this ethnic difference.

Citing Articles

Circulating resistin levels and mutation burden of the RETN gene variants predict long-term mortality in a Taiwanese population.

Hsu L, Teng M, Wu S, Liao M, Chou H, Ko Y Sci Rep. 2025; 15(1):564.

PMID: 39747951 PMC: 11695976. DOI: 10.1038/s41598-024-84142-4.


Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study.

Yoshida A, Takata Y, Tabara Y, Maruyama K, Inoue S, Osawa H J Diabetes Investig. 2024; 15(6):725-735.

PMID: 38421160 PMC: 11143422. DOI: 10.1111/jdi.14163.


Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study.

Pham T, Nimptsch K, Papadimitriou N, Aleksandrova K, Jenab M, Gunter M J Cancer Res Clin Oncol. 2023; 149(16):14889-14900.

PMID: 37599317 PMC: 10602946. DOI: 10.1007/s00432-023-05193-0.


Positive association between serum resistin and smoking was strongest in homozygotes of the G-A haplotype at c.-420 C>G and c.-358 G>A in RETN promoter: the Toon Genome Study.

Hadate T, Kawamura R, Tabara Y, Maruyama K, Takakado M, Ikeda Y J Hum Genet. 2023; 68(11):745-750.

PMID: 37423942 DOI: 10.1038/s10038-023-01176-8.


Resistin G-A haplotype at SNP-420/-358 is associated with the latent sarcopenic obesity index in the toon genome study.

Ikeda Y, Kawamura R, Takata Y, Tabara Y, Maruyama K, Takakado M J Diabetes Investig. 2023; 14(5):686-694.

PMID: 36897532 PMC: 10119914. DOI: 10.1111/jdi.13998.


References
1.
Osawa H, Onuma H, Ochi M, Murakami A, Yamauchi J, Takasuka T . Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem Biophys Res Commun. 2005; 335(2):596-602. DOI: 10.1016/j.bbrc.2005.07.122. View

2.
Banerjee R, Rangwala S, Shapiro J, Rich A, Rhoades B, Qi Y . Regulation of fasted blood glucose by resistin. Science. 2004; 303(5661):1195-8. DOI: 10.1126/science.1092341. View

3.
Patel L, Buckels A, Kinghorn I, Murdock P, Holbrook J, Plumpton C . Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 2002; 300(2):472-6. DOI: 10.1016/s0006-291x(02)02841-3. View

4.
Osawa H, Tabara Y, Kawamoto R, Ohashi J, Ochi M, Onuma H . Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care. 2007; 30(6):1501-6. DOI: 10.2337/dc06-1936. View

5.
Rangwala S, Rich A, Rhoades B, Shapiro J, Obici S, Rossetti L . Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes. 2004; 53(8):1937-41. DOI: 10.2337/diabetes.53.8.1937. View